Skip to content

LONA LONA Total Equity

Total Equity at other companies

Eli Lilly logo
Eli LillyLLY
$31.2B+97.9%
Arvinas logo
ArvinasARVN
$386.8M-41.4%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$480.48M+25.3%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$107.25M-16.2%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$21.04M-122%
Erasca, Inc. logo
Erasca, Inc.ERAS
$393.53M-1.5%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+235%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's total equity?
LONA (LONA) reported total equity of $49.3M in Q1 2026.
How has LONA's total equity changed year-over-year?
LONA's total equity increased by 32.1% year-over-year, from $37.33M to $49.3M.
What is the long-term trend for LONA's total equity?
Over 5 years (2020 to 2025), LONA's total equity has grown at a -36.7% compound annual growth rate (CAGR), from $274.28M to $27.79M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.